-
Investor Relations
- Corporate Governance
- Investor Presentations
- LIBOR Transition
- Compliance and AML
- Sustainability
- Financial Information
- Shareholders Toolkit
- FAQs
- Investors’ Queries
-
-
Accounts
- Al Hayrat Account
- Current Account
- Fixed Deposits Account
- Money Maker Account
- Salary Transfer Account
- Starmaker Account
- Super Saver Account
Al Wajaha
- Overview
BBK Lite
- Overview
NRI
- NRI Services
Debit Cards
- Classic
- Gold
- Signature
- Infinite
Self-service Banking
- ATM
- Deposit Machines
- Interactive Teller Machines
- Bank Certificates Issuance Machines
- Debit Card Issuance Machines
Foreign Exchange
- Remittance
- American Express
-
Insurance
- Home Secura
- Motor Secura
- Travel Secura
Investment
- Bonds
- IPO
- Mutual Funds
- Real Estate Investment
-
Branches and Self-Service
- Branches
- ATM
- Deposit Machines
- Debit Card Issuance Machines
- Corporate Deposit Machines
- Interactive Teller Machines
- Bank Certificates Issuance Machines
- BBK Virtual
Contactless Payments
- Apple Pay
- Samsung Wallet
- Google Pay
- Garmin Pay
- Fitbit Pay
More Ways to Bank
- New Mobile app & Online Banking
- eStatements
- BBK BanKey
- Corporate Deposit Card
- Debit Card
- Telebanking
- Open Banking
- AFAQ Payment System
Sign Language
- Sign Language Directory
-
-
-
Accounts
- Business Current Account
- Business Fixed Deposit Account
Cash Management
- Bankey eBanking
- Payroll Services
- Deposit Machines
- POS Credimax
- Remittance
-
Working Capital Finance
- Overdraft
- Cheque discounting
- Short Term Loans
Long Term Finance
- Project Finance
- Assets Finance
- Real estate Finance
-
Corporate Banking
- Government Affairs
- Real Estate, Services and Trading
- Contracting, Building Material, and Manufacturing
International Banking
- Overview
- Services
- NRI
- Offshore Branches
- Representative offices
Enterprise Banking
- Overview
-
-
-
-
FINANCIAL NEWS
Bahrain to establish USD93m insulin plant
13 Jun 2012
(MENAFN) Innovest’s CEO, Dr Khalid Abdulla, announced that Bahrain will spend USD93 million to establish the Gulf Biotic insulin plant as the number of diabetes patients in the Gulf grows rapidly, reported Arabian Business.
Abdulla said that operations at the factory, which will have an annual production capacity of 26 million units of insulin vials and cartridges, will start in 2 years.
He added that the GCC countries will be the main market for the plant’s production, as rates of diabetes in the region have reached epidemic proportions.
It is worth noting that the number of diabetic patients in the Middle East and North Africa (MENA) region, where the annual cost of treating the disease is USD5.5 billion and represents 14 percent of governments’ total healthcare spending, is forecasted to grow to 552 million by 2030 from 366 million in 2011, according to the International Diabetes Federation (IDF).
More News
12 Mar 2025
Mr. Yaser Alsharifi completes Harvard Business School Presidents’ Program in Leadership
19 Feb 2025
Bank of Bahrain and Kuwait BSC announces the transfer of HSBC Middle East, Bahrain Retail Business to BBK.
27 Jan 2025
BBK offers customers with exclusive Tas’heel and Mazaya Finance to own their dream home
15 Jan 2025
BBK Signs Strategic Partnership with Bahrain Airport Company to Develop “Express Cargo Village”
08 Jan 2025
Bank of Bahrain and Kuwait and Global Payment Services Deliver the First Advanced Fraud Prevention Solution for Wallet Provisioning in the Kingdom of Bahrain
26 Dec 2024
BBK proudly supports “Celebrate Bahrain” as a gold sponsor in cooperation with BTEA
17 Nov 2024
BBK and Asia Jewellers announce exclusive offers to its customers at Jewellery Arabia 2024
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more